EGFR targeted therapy resistance: current status, challenges, and future outlook.

ABSTRACT:

SUBMITTER: Bivona TG 

PROVIDER: S-EPMC7330318 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature